1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > World Generic Markets 16 NOVEMBER 2015

World Generic Markets 16 NOVEMBER 2015

  • November 2015
  • -
  • Espicom Business Intelligence
  • -
  • 28 pages

Industry Trend Analysis - MPP Expansion Favours Gilead
Industry Trend Analysis - LDC TRIPS Waiver Increasingly Likely To Become Permanent
Industry Trend Analysis - TPP Agreement Will Face National Implementation Battles
Industry Brief - Teva Launches Moxifloxacin In Canada
Industry Brief - Orexo Settles Fentanyl Litigation With Actavis
Industry Brief - Sun Completes InSite Acquisition
Industry Brief - Perrigo's Legal Challenges Against Mylan Denied
Industry Brief - ANI Launches Vancomycin
Industry Trend Analysis - FTC's Outlook Impedes FDA Biosimilar Naming Plans
Industry Brief - Lupin Launches Calcium Acetate In US
Industry Brief - Glenmark Gains Tentative Lacosamide Approval
Industry Brief - Sandoz Launches Fluvastatin Authorised Generic
Industry Brief - Proposed Mylan Acquisition of Perrigo Clears FTC
Industry Brief - Lupin Gains US Donepezil Approval
Industry Brief - Lupin Gains Generic Loestrin 24 Fe Approval
Industry Brief - Hikma Launches Phentolamine In US
Industry Brief - Perrigo Gains Potassium Chloride Approval
Industry Brief - AstraZeneca Secures TRO Against Dr Reddy's Esomeprazole
Industry Trend Analysis - CHS-0214 On Target For European Filing In Late 2016
Industry Brief - BI Completes Biosimilar Adalimumab Phase III Enrolment
Industry Trend Analysis - Mylan On Course To Achieve USD3bn Revenues In Q415
Industry Brief - Glenmark Enters Inhaler Agreement With Celon
Industry Brief - Dr Reddy's To Market Biocodex Products In Romania
Industry Brief - Krka Opens Notol 2 Plant
Industry Brief - mAbxience Opens European Biosimilars Facility
Industry Trend Analysis - BioMab Divestment Will Aid Cipla's Biosimilar Ambitions
Industry Trend Analysis - Dr Reddy's Revenues Rise But API Plant Issues Threaten Future Results
Industry Brief - ProBioGen and Bio Farma Enter Trastuzumab Agreement
Industry Brief - Natco Launches Ledipasvir+Sofosbuvir In Nepal
Industry Trend Analysis - Compulsory Licence Request Pressurises Government To Reform Patent Laws

Table Of Contents

World Generic Markets 16 NOVEMBER 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.